Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperglycaemia and cardiovascular risk.

F Palumbo1, C Bianchi, R Miccoli

  • 1Department of Endocrinology and Metabolism, Cisanello Hospital, Via Paradisa 2, I-56124, Pisa, Italy.

Acta Diabetologica
|January 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study.

Diabetic medicine : a journal of the British Diabetic Association·1999
Same author

5-HT4 receptor modulation of acetylcholine outflow in guinea pig brain slices.

Neuroreport·1999
Same author

Receptor-type protein-tyrosine phosphatase mu is expressed in specific vascular endothelial beds in vivo.

Experimental cell research·1999
Same author

Comparative study of the sorption of clomipramine and viloxazine hydrochlorides in Stedim 6 and PVC bags.

Bio-medical materials and engineering·1999
Same author

Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease.

Journal of autoimmunity·1999
Same author

Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients.

The American journal of gastroenterology·1999
Same journal

Combined respiratory muscle training and photobiomodulation improve systemic and tissue-specific redox homeostasis in a rat model of type 2 diabetes.

Acta diabetologica·2026
Same journal

Quality of care for migrant populations with type 2 diabetes mellitus in Italy: a retrospective analysis of data from the the Italian AMD (Associations of Medical Diabetologists) annals initiative.

Acta diabetologica·2026
Same journal

Bidirectional association between obstructive sleep apnea and diabetic retinopathy: a severity-stratified systematic review and meta-analysis with GRADE assessment.

Acta diabetologica·2026
Same journal

Therapeutic strategies to enhance proliferation in diabetic wound contraction: a comprehensive review from 1991-2025.

Acta diabetologica·2026
Same journal

Adjunctive use of glucagon-like peptide-1 receptor agonists after bariatric surgery: updated systematic review and meta-analysis of randomized controlled trials.

Acta diabetologica·2026
Same journal

Clarifying metformin exposure when interpreting glycemic responses after imeglimin initiation.

Acta diabetologica·2026
See all related articles

Type 2 diabetes significantly increases cardiovascular disease risk, comparable to prior heart attacks. Managing hyperglycemia and associated metabolic factors is crucial for reducing mortality in these patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome Research

Background:

  • Cardiovascular diseases (CVD) are the leading cause of mortality globally.
  • Type 2 diabetes mellitus (T2DM) patients face a disproportionately high risk of CVD mortality.
  • This risk in T2DM patients equals that of non-diabetics post-myocardial infarction.

Purpose of the Study:

  • To highlight the significant contribution of hyperglycemia to cardiovascular morbidity and mortality in T2DM.
  • To emphasize hyperglycemia's role as a cardiovascular risk multiplier.
  • To advocate for comprehensive assessment and management of glycemic control and metabolic syndrome components.

Main Methods:

  • Review of existing literature on diabetes, hyperglycemia, and cardiovascular outcomes.

Related Experiment Videos

  • Analysis of risk factors contributing to cardiovascular mortality in T2DM patients.
  • Discussion of treatment strategies focusing on glycemic control and metabolic syndrome.

    • Main Results:

    • Hyperglycemia exacerbates cardiovascular morbidity and mortality in diabetes mellitus.
    • Diabetic patients often present with multiple, co-existing risk factors, amplifying cardiovascular risk.
    • Effective management necessitates a thorough evaluation of glycemic control and metabolic syndrome.

    Conclusions:

    • Comprehensive management of T2DM must address both glycemic control and associated metabolic factors.
    • Targeting hyperglycemia and the broader metabolic syndrome is essential for reducing cardiovascular risk in diabetic patients.